Contact this trialFirst, we need to learn more about you.
Nucleoside Reverse Transcriptase Inhibitor
GSK3640254 + ABC/3TC + FTC/TAF + Dolutegravir for Human Immunodeficiency Virus Infection
Recruiting0 awardsPhase 2
Berkley, Michigan
This trial will compare the safety and efficacy of GSK3640254 to the DTG, each given with 2 NRTIs, in order to find the best dose of GSK3640254.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.